CRISPR Therapeutics AG (CRSP) Return on Assets [ROA] (2016 - 2026)
CRISPR Therapeutics AG's Return on Assets [ROA] was -17.52% in Q3 2026, up 5.32 percentage points from -22.84% a year earlier but down 0.74 percentage points from the prior quarter.
Powered by 
Analysis
CRISPR Therapeutics AG (CRSP) Return on Assets [ROA] (2016 - 2026) Analysis & Trends
For FY2025, Return on Assets [ROA] at CRISPR Therapeutics AG came in at -25.81%, down 9.43 percentage points from FY2024.
- Return on Assets [ROA] shows a five-year change of -1.70 percentage points (FY2020 to FY2025).
- In earlier years, Return on Assets [ROA] was -16.38% in FY2024 (-9.51 pp), -6.87% in FY2023 (+19.16 pp), -26.03% in FY2022 (-42.53 pp) and 16.49% in FY2021 (+40.60 pp).
- Quarterly Return on Assets [ROA] has moved between -28.29% (Q4 2022) and 13.55% (Q4 2021) over five years.
- Compared with a year earlier, Return on Assets [ROA] was higher in two of the last eight quarters, with an average year-over-year change of -5.61 percentage points.
- The best year-over-year quarter for Return on Assets [ROA] over five years was Q4 2021 (a gain of 34.61 percentage points); the worst was Q2 2022 (a drop of 43.38 percentage points).
- Per Business Quant data, CRSP's Return on Assets [ROA] in the three quarters before Q3 2026 was -16.78% (Q2 2026), -22.78% (Q1 2026) and -25.79% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 19.00% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 8.08% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 7.32% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 1.87% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 9.36% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 9.80% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -7.67% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 2.00% |
| 10 | CRISPR Therapeutics AG | 4.37 Bn | -4.68 Bn | - | -18.25% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -18.25% |
| Jun 30, 2026 | -17.10% |
| Mar 31, 2026 | -23.03% |
| Dec 31, 2025 | -25.66% |
| Sep 30, 2025 | -23.11% |
| Jun 30, 2025 | -21.97% |
| Mar 31, 2025 | -17.24% |
| Dec 31, 2024 | -16.29% |
| Sep 30, 2024 | -9.67% |
| Jun 30, 2024 | -10.87% |
| Mar 31, 2024 | -8.97% |
| Dec 31, 2023 | -6.30% |
| Sep 30, 2023 | -15.78% |
| Jun 30, 2023 | -18.21% |
| Mar 31, 2023 | -23.02% |
| Dec 31, 2022 | -28.75% |
| Sep 30, 2022 | -29.16% |
| Jun 30, 2022 | -25.77% |
| Mar 31, 2022 | 11.02% |
| Dec 31, 2021 | 13.37% |
API Access
CRISPR Therapeutics AG Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=CRSP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "CRSP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=CRSP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();